VIKING GLOBAL TECHNOLOGIES ANNOUNCES VKIN-300 RECEIVES FORMAL FRENCH ATTESTATION OF CONFORMITY
Viking Global Technologies, Inc. (VGTK) filed an SEC Form 8-K — Other Events. EXHIBIT 99.1 FOR IMMEDIATE RELEASE VIKING GLOBAL TECHNOLOGIES ANNOUNCES VKIN-300 RECEIVES FORMAL FRENCH ATTESTATION OF CONFORMITY Formal attestation marks completion of key French regulatory milestone and supports advancement of international commercialization efforts HOUSTON, TE
How this was made
The 30-second read
Why it matters
The attestation confirms the equipment meets identified regulatory and normative requirements, including a minimum average ozone concentration requirement, and is valid through Oct. 27, 2031. This can strengthen commercialization credibility with healthcare and waste-management customers, but the company explicitly notes it does not constitute approval in other jurisdictions and does not guarantee purchases or revenue.
Market read
Traders can treat this as a concrete regulatory progress update that may improve commercialization odds, but it lacks quantified financial impact or contract announcements.
What to watch
The attestation applies specifically to the VKIN-300 SD configuration and remains subject to continuing requirements and potential validity challenges if product requirements change or equipment is modified.
Background
The 8-K (Item 7.01 Regulation FD, Item 8.01 Other Events) reports that Viking Ozone, a majority-owned subsidiary of Viking Global Technologies, received LNE’s formal Attestation of Conformity for the VKIN-300 SD configuration under French standard NF X 30-503-1:2024.
Ticker impact
Viking Global Technologies disclosed via 8-K that its VKIN-300 received formal French Attestation of Conformity from LNE, issued Oct. 28, 2026.
Likely modest positive bias as traders price improved regulatory readiness for international commercialization, tempered by OTC liquidity and the lack of revenue guidance.
The filing is a primary disclosure of a specific conformity attestation number, validity window, and certified configuration, but it does not quantify financial impact or provide near-term order commitments.
Market effects
Highlights regulatory pathway progress for ozone-based medical waste treatment alternatives, potentially supportive for niche environmental/healthcare waste tech sentiment.
Improves prospects for French/EU commercialization of the VKIN-300 SD configuration by satisfying a previously outstanding conformity requirement.
May serve as a technical reference for other international markets, but site-specific approvals and customer adoption remain uncertain.
Counterpoint
A conformity attestation is not the same as procurement or revenue; without disclosed customer contracts, the market may discount the impact.
Key entities
- companyViking Global Technologies, Inc.
OTCQB-listed parent company filing the 8-K and announcing the VKIN-300 French conformity milestone.
- subsidiaryViking Ozone Technology, LLC
Majority-owned subsidiary that received the LNE attestation for the VKIN-300 SD configuration.
- regulator/testing bodyLaboratoire national de métrologie et d’essais (LNE)
French national laboratory for metrology and testing that issued the formal Attestation of Conformity (No. 41506-0).
- standardNF X 30-503-1:2024
French standard incorporated into the regulatory framework governing pretreatment by disinfection of infectious healthcare waste.
- product configurationVKIN-300 SD configuration
The specific certified configuration covered by the attestation, with validity through Oct. 27, 2031.
